Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 08, 2014 issue
Ebberts and colleagues compare the efficacy and safety of varenicline and sustained-release bupropion vs varenicline alone in 506 adult cigarette smokers in a randomized, blinded, placebo-controlled, 12-week clinical trial (52-week follow-up) at 3 centers from October 2009 through April 2013.
Holford and coauthors used National Health Interview Surveys to assess cigarette smoking histories for the US adult population and model reductions in smoking-related mortality associated with implementation of tobacco control since 1964, when the first surgeon general’s report on smoking and health was released.
To examine associations between tobacco use and mental illness, Cook and coauthors used nationally representative surveys of noninstitutionalized US residents to compare trends in smoking rates between adults with and without mental illness and to compare rates of smoking cessation among adults with mental illness who did and did not receive mental health treatment.
Ng and coauthors estimated the prevalence of daily smoking by age and sex and the number of cigarettes per smoker per day for 187 countries from 1980 to 2012.